Stephanie Yi, MD
Surgery · Houston, TXNPI 1437387842
Payments from drug & device makers
What this record shows
This record is dominated by education: $6,050 of the $7,240 with a category attached, or 83.6%. Intuitive Surgical accounts for 83.3% of it on its own, with 19 other manufacturers making up the rest. Reporting peaked in 2021 at $6,048 and has fallen 97.7% since, to $139 in 2025.
Across 40 payments — averaging $181.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$6K
- Sanofi-aventis U.S. LLC$283
- Veloxis Pharmaceuticals, Inc.$185
- Gilead$109
- Organogenesis Inc.$106
- Shionogi Inc$94
- plus $434 from 14 others
What the payments were for
- Food & beverage$1,19016%
- Education$6,05084%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 4 | $6,030 |
| Sanofi-aventis U.S. LLC | 3 | $283 |
| Veloxis Pharmaceuticals, Inc. | 5 | $185 |
| Gilead | 1 | $109 |
| Organogenesis Inc. | 1 | $106 |
| Shionogi Inc | 5 | $94 |
| TELA Bio, Inc. | 4 | $63 |
| Baxter Healthcare | 1 | $61 |
| AstraZeneca(2 entities) | 3 | $60 |
| Vifor Pharma, Inc. | 2 | $37 |
| Sanofi | 2 | $37 |
| Johnson & Johnson | 1 | $25 |
| Smith+Nephew | 1 | $24 |
| Eisai Inc. | 1 | $22 |
| Merck | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| AbbVie | 1 | $18 |
| Fujifilm Wako Diagnostics U.S.A. Corporation | 1 | $16 |
| Endo Pharmaceuticals Inc. | 1 | $15 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$6,000
- THYMOGLOBULIN$241
- Epclusa$109
- PuraPly$106
How this compares
$7,240 in reported general payments places this provider in the 65th percentile of 1,830 surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other surgery in Houston
- James SuliburkHouston$161K
- Funda MericHouston$141K
- Jonathan StahlHouston$105K
- Richard KnightHouston$103K
- Tanyaradzwa KajeseHouston$92K
- Michael HarkinsTomball$2.7M
- Douglas StoddardAustin$1.4M
- Steven FassAustin$989K
- Vineet ChoudhryAustin$851K
- Andy HawthorneRound Rock$843K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.